172. Prevalence and Impact of Complementary and Alternative Medicine Use Among Multiple Sclerosis Patients in Saudi Arabia

Salman Aljarallah,Sarah Alquwayz,Ghadh Alsadhan,Raghad Almubarak,Saleh Aldeligan

DOI: https://doi.org/10.1016/j.msard.2024.106133

IF: 4.808

2024-12-15

Multiple Sclerosis and Related Disorders

Abstract:Background/Objective(s) Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease affecting the central nervous system, characterized by episodic flare-ups and progressive disability. The use of complementary and alternative medicine (CAM) is increasingly prevalent among MS patients worldwide, particularly in regions like Saudi Arabia, where cultural and religious factors influence healthcare choices. Material(s) and Method(s) Our study is an observational cross-sectional questionnaire-based study of patients diagnosed with MS in KKUH, Riyadh, Saudi Arabia in 2022-2023. Study participants included patients who were above 18 years old and diagnosed with clinically definite multiple sclerosis based on the 2017 mcdonald's criteria who attended the medical day unit for their scheduled infusion therapy and gave verbal consent to participate. The data was collected using a questionnaire that consisted of 5 sections . The first section contains the demographics of the participant, the second section is about disease characteristics, the third section assesses the trust in physicians using the wake forest physician trust scale The fourth section included a 1 to 5 scale about the participants' belief in the COVID-19 vaccine . The last section was about complementary and alternative medicine use using the (I-CAM-Q) questionnaire. Result(s) A study of 89 MS patients at KKUH in Riyadh. We have found that 44.9% of MS patients reported using CAM, with vitamins and minerals being the most common modalities. High income, male gender, and moderate attitudes towards medication safety were significantly associated with CAM use (p < 0.05). Despite high compliance with conventional medications, a notable proportion of patients expressed low trust in their physicians. Most patients who used CAM did so based on recommendations from family and friends, and some reported improvements in symptoms such as mobility, mood, and cognition. However, few patients discussed their CAM use with their physicians, highlighting a gap in communication. Conclusion(s) The study reveals a significant prevalence of CAM use among MS patients in Saudi Arabia, largely influenced by cultural and familial factors. These findings highlight the need for improved physician-patient communication regarding CAM, particularly as it can affect treatment adherence and patient outcomes. Healthcare providers should proactively discuss CAM to ensure safe and integrated care for MS patients. Researching effective communication strategies, including the development of guidelines or tools, would facilitate these discussions. Additionally, further investigation is needed to understand the low trust levels in physicians among MS patients, utilizing qualitative methods like interviews or focus groups to gain deeper insights into their experiences and expectations regarding conventional treatments. A limitation of this study is its observational cross-sectional design, which captures CAM usage at a single point in time and does not establish causality or track changes over time.

clinical neurology